Stockreport

Acrivon Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference

Acrivon Therapeutics, Inc.  (ACRV) 
PDF WATERTOWN, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biotechnology com [Read more]